{"meshTags":["Comparative Genomic Hybridization","Mice, Knockout","Glioblastoma","Genomics","Tumor Suppressor Protein p53","Astrocytoma","PTEN Phosphohydrolase","Gene Expression Profiling","Brain Neoplasms","Retinoblastoma Protein","Mice","Animals","Humans","Models, Genetic"],"meshMinor":["Comparative Genomic Hybridization","Mice, Knockout","Glioblastoma","Genomics","Tumor Suppressor Protein p53","Astrocytoma","PTEN Phosphohydrolase","Gene Expression Profiling","Brain Neoplasms","Retinoblastoma Protein","Mice","Animals","Humans","Models, Genetic"],"genes":["TP53","PTEN","RB1"],"organisms":["10090","9606"],"publicationTypes":["Comment","Journal Article"],"abstract":"Malignant gliomas are characterized by accumulated aberrations affecting TP53, PTEN, and RB1 signaling. In this issue, Chow etÂ al. discover that combinatorial loss of these tumor suppressors in mice induces gliomas with unexpected degrees of similarity to human pathologic, genomic, and expression subclasses recently revealed by large-scale genomic studies.","title":"Glioma models: new GEMMs add \"class\" with genomic and expression correlations.","pubmedId":"21397851"}